Patents Assigned to Central Laboratory of The Netherlands Red Cross Blood Tranfusion Service
  • Patent number: 6242414
    Abstract: Methods of treatment and prevention of diseases associated with release of neutrophil elastase and IL-8 by administration of TFPI, and analogs of TFPI are disclosed. Methods of determining efficacy of treatment with TFPI, patient's responsiveness to treatment with TFPI and the ultimate determination of patient prognosis are also disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 5, 2001
    Assignees: Chiron Corporation, Central Laboratory of The Netherlands Red Cross Blood Tranfusion Service
    Inventors: Kirk Johnson, Abla A. Creasey, Lucien A. Aarden